Healing Touch, Quality of Life, and Immunity During Breast Cancer Treatment

Breast Cancer Clinical Trial

Official title:

Quality of Life and Immunity During Breast Cancer Treatment

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00565305
• Other study ID #: 200305053
• Status: Completed
• Phase: N/A
• First received: November 28, 2007
• Last updated: March 13, 2017
• Start date: July 2003
• Est. completion date: November 2009

Study information

• Verified date: March 2017
• Source: University of Iowa
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this research study is to understand effects of a complementary medicine therapy, Healing Touch on quality of life and immunity of patients who are receiving treatment for breast cancer. Healing Touch is a Holistic Therapy used as an adjunct to medical treatment. The goal of Healing Touch is to restore energy and vitality to the body as a patient is receiving treatment for cancer. Treatments include light touch on specific points on the body as well as around the body, to increase well-being and support the body's ability to heal. Healing Touch has been shown to increase relaxation and well-being and to decrease anxiety, pain, and treatment side effects in a variety of illnesses including cancer. Although Healing Touch is frequently used by cancer patients along with their medical treatments, very little is understood about the effects of this treatment on the immune system. The immune system is known to be important in the body's response to fighting cancer. We are studying Healing Touch to help us understand whether or not these treatments are effective in supporting the immune system during breast cancer treatment

Aim 1. To evaluate effects of a healing touch (HT) intervention on cellular immunity among early stage breast cancer patients during radiotherapy.

Aim 2. To evaluate effects of a Healing Touch (HT) intervention on cytokines associated with radiation damage and acute skin reactions in early stage breast cancer patients during radiotherapy.

Aim 3. To evaluate the effects of a Healing Touch intervention on fatigue and mood in early stage breast cancer patients during radiation treatment.

Description:

Breast cancer patients use Complementary and Alternative Medicine (CAM) in greater proportions than any other group of cancer patients. The primary reason breast cancer patients cite for use of CAM is strengthening the immune system. Healing touch (HT) is a CAM treatment frequently used by cancer patients to reduce adverse side effects of chemotherapy and radiation and to enhance immunity. HT is classified by NIH as a "biofield" therapy as its effects are proposed to be secondary to manipulation of "energy fields" around the body of a patient. A recent meta-analysis has demonstrated relatively large effects of HT on well-being and on physiological parameters, even from brief treatments. However, to date, there are no data on the effects of HT on immune function among breast cancer patients during treatment. This is particularly important as several immune parameters show long-term suppression or alteration, particularly after combined adjuvant chemotherapy and radiation among breast cancer patients. Additionally, there are no data on the effects of HT on the common side effects of breast cancer treatment which can include profound fatigue and radiation-induced skin damage. Physiological mechanisms underlying possible effects of HT are also poorly understood. This study is designed to reduce this knowledge gap by examining how HT affects cellular immune function and biomarkers related to two of the most problematic side effects of breast cancer treatment, fatigue and radiation-induced tissue damage. Effects on the subjective experience of fatigue and clinician rated skin damage will also be noted. Participants will be 42 early stage breast cancer patients who are receiving a standard course of radiotherapy following breast conservation surgery or mastectomy who have either had chemotherapy or not

The significance of the project is as follows. If positive effects are demonstrated on intermediate outcomes such as immune parameters, markers of radiation damage, and/or fatigue, follow-up studies would be warranted examining effects of HT on a) recurrence and survival, b) incidence of long term side effects of radiation, c) quality of life among breast cancer patients. Additionally, if effects of HT are demonstrated, a critical examination of putative mechanisms of action, using controls for effect of attention, expectation, and other placebo effects will be warranted.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 150
• Est. completion date: November 2009
• Est. primary completion date: June 2008
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 95 Years

Eligibility

Inclusion Criteria:

• Breast cancer patients who have received either a mastectomy or breast conservative surgery

• Diagnosis of Stage I-IIIa breast cancer,

• Receiving either chemotherapy + radiation or radiation alone

Exclusion Criteria:

• Past history of cancer

• Recurrent cancer

• Greater than Stage IIIa breast cancer

• History of immunosuppressive disorders (e.g. HIV, AIDS, hepatitis, etc.)

• On immunosuppressive medications

• On corticosteroids (e.g. Prednisone)

Related Conditions & MeSH terms

• Breast Cancer
• Breast Neoplasms

Intervention

Behavioral:
• Healing Touch
Healing Touch (HT) is a non-invasive therapeutic approach to healing which describes its mode of action as using touch to modulate the patient's energy system. The goal of HT is to restore harmony and balance in the patient's energy system to assist the person to self-heal.88 Healing Touch, as used here, refers to the techniques taught in Mentgen's standardized curriculum of Healing Touch offered through Healing Touch International and endorsed by the American Holistic Nurse's Association

Radiation:
• Standard Treatment
4-6 cycles of cytotoxic chemotherapy followed by 5040 cGy of external beam whole breast radiotherapy in 28 fractions usually followed by a boost of 1000-1600 cGy

Locations

Country	Name	City	State
United States	Holden Comprehensive Cancer Center, University of Iowa	Iowa City	Iowa

Sponsors (2)

Lead Sponsor	Collaborator
University of Iowa	Department of Health and Human Services

Country where clinical trial is conducted

United States, 

References & Publications (25)

Archambeau JO, Pezner R, Wasserman T. Pathophysiology of irradiated skin and breast. Int J Radiat Oncol Biol Phys. 1995 Mar 30;31(5):1171-85. Review. — View Citation

Astin JA, Harkness E, Ernst E. The efficacy of "distant healing": a systematic review of randomized trials. Ann Intern Med. 2000 Jun 6;132(11):903-10. Review. — View Citation

Bogulawski M. Therapeutic touch: a facilitator of pain relief. Top Clin Nurs. 1980 Apr;2(1):27-37. — View Citation

Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol. 2000 Feb;18(4):743-53. — View Citation

Freel M, Hart L. Nurse's handbook of Alternative & Complementary therapies. Apringhouse, PA: Springhouse Publishing Co.: 61-82, 1999.

Hamaoka T, Fujiwara H. Phenotypically and functionally distinct T-cell subsets in anti-tumor responses. Immunol Today. 1987;8(9):267-9. doi: 10.1016/0167-5699(87)90186-1. Review. — View Citation

Hung K, Hayashi R, Lafond-Walker A, Lowenstein C, Pardoll D, Levitsky H. The central role of CD4(+) T cells in the antitumor immune response. J Exp Med. 1998 Dec 21;188(12):2357-68. — View Citation

Jacobson JS, Verret WJ. Complementary and alternative therapy for breast cancer: the evidence so far. Cancer Pract. 2001 Nov-Dec;9(6):307-10. — View Citation

Keller E, Bzdek VM. Effects of therapeutic touch on tension headache pain. Nurs Res. 1986 Mar-Apr;35(2):101-6. — View Citation

Levy S, Herberman R, Lippman M, d'Angelo T. Correlation of stress factors with sustained depression of natural killer cell activity and predicted prognosis in patients with breast cancer. J Clin Oncol. 1987 Mar;5(3):348-53. — View Citation

Levy SM, Herberman RB, Lee J, Whiteside T, Kirkwood J, McFeeley S. Estrogen receptor concentration and social factors as predictors of natural killer cell activity in early-stage breast cancer patients. Confirmation of a model. Nat Immun Cell Growth Regul — View Citation

Levy SM, Herberman RB, Maluish AM, Schlien B, Lippman M. Prognostic risk assessment in primary breast cancer by behavioral and immunological parameters. Health Psychol. 1985;4(2):99-113. — View Citation

Lindley C, Vasa S, Sawyer WT, Winer EP. Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer. J Clin Oncol. 1998 Apr;16(4):1380-7. — View Citation

Melief CJ. Tumor eradication by adoptive transfer of cytotoxic T lymphocytes. Adv Cancer Res. 1992;58:143-75. Review. — View Citation

Menthe J. Healing touch level I notebook, 1996.

Morris KT, Johnson N, Homer L, Walts D. A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites. Am J Surg. 2000 May;179(5):407-11. — View Citation

Oberst MT, Hughes SH, Chang AS, McCubbin MA. Self-care burden, stress appraisal, and mood among persons receiving radiotherapy. Cancer Nurs. 1991 Apr;14(2):71-8. — View Citation

Quinn JF. Therapeutic touch as energy exchange: testing the theory. ANS Adv Nurs Sci. 1984 Jan;6(2):42-9. — View Citation

Tichatschek E, Zielinski CC, Müller C, Sevelda P, Kubista E, Czerwenka K, Spona J, Wolf H, Eibl MM. Long-term influence of adjuvant therapy on natural killer cell activity in breast cancer. Cancer Immunol Immunother. 1988;27(3):278-82. — View Citation

Whiteside TL, Herberman RB. Role of human natural killer cells in health and disease. Clin Diagn Lab Immunol. 1994 Mar;1(2):125-33. Review. — View Citation

Wirth D, Barret M, Eidelman W. Non-contact therapeutic touch and wound re-epithelialization: An extension of previous research. Complementary Therapies in Medicine 2:187-192, 1994.

Wirth D, Brenlan D, Levine R, Rodriguez C. The effect of complementary healing therapy on postoperative pain after surgical removal of impacted third molar teeth. Complementary Therapies in Medicine 2:187-192, 1994.

Wirth D, Richardson J, Eidelman W, O'Malley A. Full thickness dermal wounds treated with non-contact therapeutic touch: A replication and extension. Complemenatary Therapies in Medicine 1:127-132, 1993.

Wirth D. The effect of non-contact therapeutic touch on the healing rate of full thickness dermal wounds. Subtle Energies 1:1-20, 1990.

Wirth DP, Richardson JT, Eidelman WS. Wound healing and complementary therapies: a review. J Altern Complement Med. 1996 Winter;2(4):493-502. Review. — View Citation

* Note: There are 25 references in all — Click here to view all references

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	NK cell activity; sTNFRII; IL-1ra; fatigue (FSI); depression (CES-D); acute skin reactions		six weeks
Secondary	WBC, distress (POMS), sleep quality, days of interrupted treatment		six weeks